A new deep learning model called GMAP can predict critical glioma mutations directly from standard pathology slides, offering a cost-effective alternative to expensive genomic testing. Original paper: Molecular alterations prediction in gliomas via an interpretable deep learning model: a multicentre and retrospective study. — The Lancet. Digital health. 10.1016/j.landig.2025.100977 📄 Read the article